1- ((2- (5- dimethylamino)naphthalene- 1- sulfonylaminoethyl)amino)- 3- (1- naphthaleneoxy)- 2- propanol

Also Known As:

DAPN

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Mononeuropathies (Mononeuritis Multiplex) 01/01/2017 - "Distal symmetric sensory motor polyneuropathy was found in 62% of the patients, autonomic neuropathy in 25.6%, somatic mononeuropathy in 28.5%, DAPN in 7.9%. "
2.	Polyneuropathies (Polyneuropathy) 01/01/2017 - "Distal symmetric sensory motor polyneuropathy was found in 62% of the patients, autonomic neuropathy in 25.6%, somatic mononeuropathy in 28.5%, DAPN in 7.9%. "
3.	Paresthesia (Dysesthesia) 01/01/2017 - "Pain and paresthesia in a zone of innervation of several roots and nerves, amyotrophy that spread beyond the definite myotome were key symptoms of DAPN. "
4.	Pain (Aches) 01/01/2017 - "Pain and paresthesia in a zone of innervation of several roots and nerves, amyotrophy that spread beyond the definite myotome were key symptoms of DAPN. "